Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PRA Stock Forecast 2026-2027
$24.71
Current Price
$1.28B
Market Cap
Buy 0
Hold 3
Sell 1
Wall St Analyst Ratings
Distance to PRA Price Targets
+1.2%
To High Target of $25.00
+1.2%
To Median Target of $25.00
+1.2%
To Low Target of $25.00
PRA Price Momentum
+3.0%
1 Week Change
+0.4%
1 Month Change
+6.7%
1 Year Change
+2.3%
Year-to-Date Change
-0.6%
From 52W High of $24.85
+8.8%
From 52W Low of $22.72
📊 TOP ANALYST CALLS
Did PRA Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if ProAssurance is one of their latest high-conviction picks.
Latest PRA Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, PRA has a neutral consensus with a median price target of $25.00 (ranging from $25.00 to $25.00). The overall analyst rating is Hold (5.5/10). Currently trading at $24.71, the median forecast implies a 1.2% upside. This outlook is supported by 0 Buy, 3 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Paul Newsome at Piper Sandler, projecting a 1.2% upside. Conversely, the most conservative target is provided by Paul Newsome at Piper Sandler, suggesting a 1.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PRA Analyst Ratings
0
Buy
3
Hold
1
Sell
PRA Price Target Range
Low
$25.00
Average
$25.00
High
$25.00
Current: $24.71
Latest PRA Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PRA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 8, 2025 | Piper Sandler | Paul Newsome | Neutral | Maintains | $25.00 |
| Apr 3, 2025 | Citizens Capital Markets | Market Perform | Downgrade | $N/A | |
| Feb 25, 2025 | Citizens Capital Markets | Market Outperform | Reiterates | $N/A | |
| Nov 12, 2024 | Truist Securities | Hold | Maintains | $N/A | |
| Aug 12, 2024 | Truist Securities | Hold | Maintains | $N/A | |
| Jul 17, 2024 | JMP Securities | Market Outperform | Maintains | $N/A | |
| May 8, 2024 | Truist Securities | Hold | Maintains | $N/A | |
| Apr 15, 2024 | JMP Securities | Market Outperform | Reiterates | $N/A | |
| Mar 4, 2024 | Piper Sandler | Overweight | Maintains | $N/A | |
| Feb 29, 2024 | JMP Securities | Market Outperform | Maintains | $N/A | |
| Feb 29, 2024 | Truist Securities | Hold | Maintains | $N/A | |
| Jan 17, 2024 | JMP Securities | Market Outperform | Maintains | $N/A | |
| Nov 20, 2023 | Piper Sandler | Overweight | Maintains | $N/A | |
| Nov 10, 2023 | Truist Securities | Hold | Maintains | $N/A | |
| Oct 6, 2023 | Piper Sandler | Overweight | Maintains | $N/A | |
| Jul 12, 2023 | JMP Securities | Market Outperform | Maintains | $N/A | |
| Jul 6, 2023 | Piper Sandler | Overweight | Maintains | $N/A | |
| May 31, 2023 | Piper Sandler | Overweight | Maintains | $N/A | |
| May 30, 2023 | Piper Sandler | Overweight | Maintains | $N/A | |
| May 17, 2023 | Truist Securities | Hold | Maintains | $N/A |
ProAssurance Corporation (PRA) Competitors
The following stocks are similar to ProAssurance based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ProAssurance Corporation (PRA) Financial Data
ProAssurance Corporation has a market capitalization of $1.28B with a P/E ratio of 19.6x. The company generates $1.10B in trailing twelve-month revenue with a 6.0% profit margin.
Revenue growth is -4.9% quarter-over-quarter, while maintaining an operating margin of +6.6% and return on equity of +5.1%.
Valuation Metrics
Market Cap
$1.28B
Enterprise Value
$1.36B
P/E Ratio
19.6x
PEG Ratio
-0.1x
Price/Sales
1.2x
Growth & Margins
Revenue Growth (YoY)
-4.9%
Gross Margin
N/A
Operating Margin
+6.6%
Net Margin
+6.0%
EPS Growth
-3.1%
Financial Health
Cash/Price Ratio
+26.6%
Current Ratio
2.1x
Debt/Equity
32.4x
ROE
+5.1%
ROA
+1.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
ProAssurance Corporation (PRA) Business Model
About ProAssurance Corporation
What They Do
Provides healthcare professional liability insurance.
Business Model
ProAssurance Corporation generates revenue by offering specialized liability insurance products to medical professionals and healthcare institutions. Its business model focuses on addressing the unique risk profiles of various healthcare specialties, allowing the company to tailor its services and pricing to meet the specific needs of its clients.
Additional Information
The company plays a critical role in the healthcare sector by providing financial protection against litigation risks, enabling practitioners to focus on patient care. ProAssurance's commitment to adapting its offerings to changing healthcare regulations underscores its dedication to supporting the resilience of the healthcare system.
Company Information
Sector
Financial Services
Industry
Insurance - Property & Casualty
Employees
972
CEO
Mr. Edward Lewis Rand Jr., CPA
Country
United States
IPO Year
1991
Website
www.proassurance.comProAssurance Corporation (PRA) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Why Is ProAssurance (PRA) Down 0.7% Since Last Earnings Report?
ProAssurance (PRA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Jun 04, 2026
By Zacks Equity Research
Realtime BLOG
FUTU Q1 Earnings Fall Y/Y Due to RMB1.85B CSRC Penalty, Revenues Miss
Futu's Q1 2026 revenues rise 24.7% but miss estimates, while net income sinks over 60% as an RMB1.85B proposed CSRC penalty hits results.
Jun 01, 2026
By Zacks Equity Research
Analyst Blog
Latest News
Quick Summary
PRA met Q1 earnings estimates due to reduced expenses and increased investment income, which balanced declines in premiums across its segments.
Why It Matters
PRA's earnings stability despite declining premiums signals effective cost management and investment strategies, which may enhance investor confidence and influence stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
ProAssurance Corporation (NYSE: PRA) reported Q1 2026 net income of $8.5 million ($0.16/share) and operating income of $12.7 million ($0.25/share), showing progress in premium rates amid challenging conditions.
Why It Matters
ProAssurance's net and operating income figures indicate financial stability and growth potential, which could enhance investor confidence and affect stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
ProAssurance (PRA) reported revenue and EPS for Q1 2026; investors should compare these figures with Wall Street estimates and year-ago performance for a comprehensive analysis.
Why It Matters
ProAssurance's revenue and EPS performance relative to Wall Street estimates and previous year figures will influence investor sentiment and stock valuation.
Source: Zacks Investment Research
Market Sentiment:
Positive
ProAssurance (PRA) Matches Q1 Earnings Estimates
1 month ago
Quick Summary
ProAssurance (PRA) reported quarterly earnings of $0.25 per share, matching the Zacks Consensus Estimate and up from $0.13 per share year-over-year.
Why It Matters
ProAssurance's earnings meeting expectations and showing significant year-over-year growth signals stability and potential for future profitability, impacting investor confidence and stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
ProAssurance (PRA) may not meet expectations for an earnings beat in its upcoming report due to lacking key performance indicators. Investors should stay informed.
Why It Matters
ProAssurance's lack of favorable earnings indicators may signal weaker financial performance, potentially impacting stock prices and investor confidence.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
ProAssurance (PRA) recently reported earnings. Investors should monitor upcoming developments and performance metrics for insights on the stock's future.
Why It Matters
ProAssurance's recent earnings report may influence stock performance, affecting investor sentiment and potential price movement. Future guidance and market reactions are critical for investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About PRA Stock
What is ProAssurance Corporation's (PRA) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, ProAssurance Corporation (PRA) has a median price target of $25.00. The highest price target is $25.00 and the lowest is $25.00.
Is PRA stock a good investment in 2026?
According to current analyst ratings, PRA has 0 Buy ratings, 3 Hold ratings, and 1 Sell ratings. The stock is currently trading at $24.71. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PRA stock?
Wall Street analysts predict PRA stock could reach $25.00 in the next 12 months. This represents a 1.2% increase from the current price of $24.71. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is ProAssurance Corporation's business model?
ProAssurance Corporation generates revenue by offering specialized liability insurance products to medical professionals and healthcare institutions. Its business model focuses on addressing the unique risk profiles of various healthcare specialties, allowing the company to tailor its services and pricing to meet the specific needs of its clients.
What is the highest forecasted price for PRA ProAssurance Corporation?
The highest price target for PRA is $25.00 from Paul Newsome at Piper Sandler, which represents a 1.2% increase from the current price of $24.71.
What is the lowest forecasted price for PRA ProAssurance Corporation?
The lowest price target for PRA is $25.00 from Paul Newsome at Piper Sandler, which represents a 1.2% increase from the current price of $24.71.
What is the overall PRA consensus from analysts for ProAssurance Corporation?
The overall analyst consensus for PRA is neutral. Out of 2 Wall Street analysts, 0 rate it as Buy, 3 as Hold, and 1 as Sell, with a median price target of $25.00.
How accurate are PRA stock price projections?
Stock price projections, including those for ProAssurance Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 6, 2026 10:17 AM UTC